Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CC
CC logo

CC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chemours Co (CC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
23.170
1 Day change
-0.64%
52 Week Range
24.130
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Chemours Co (CC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bullish technical indicators, positive analyst sentiment with multiple price target upgrades, and a favorable options sentiment. Despite some financial challenges, the company's valuation and diversification into refrigerants provide a strong case for long-term growth.

Technical Analysis

The stock exhibits bullish technical indicators with a positively expanding MACD histogram (0.119), bullish moving averages (SMA_5 > SMA_20 > SMA_200), and a price above key resistance levels (R1: 23.743). The RSI_6 at 79.277 is in the neutral zone, not signaling overbought or oversold conditions.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate strong bullish sentiment in the options market, with higher call activity compared to puts.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Multiple analyst price target upgrades, with the latest targets ranging from $25 to $29, indicating confidence in the stock's upward potential.

  • Diversification into refrigerants and higher North American exposure within TiO2, which analysts view as attractive.

  • Bullish technical indicators and favorable options sentiment.

Neutral/Negative Catalysts

  • Financial challenges in Q4 2025, including a revenue decline (-2.13% YoY) and a negative net income of -$61M, though net income improved significantly YoY.

  • Gross margin dropped significantly (-39.19% YoY), which could indicate cost pressures.

Financial Performance

In Q4 2025, revenue declined by -2.13% YoY to $1.33B, while net income improved by 408.33% YoY to -$61M. EPS also increased by 412.50% YoY to -$0.41. However, gross margin dropped significantly to 11.95% (-39.19% YoY), reflecting potential cost challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is highly positive, with multiple firms raising price targets recently. RBC Capital, UBS, Truist, and Mizuho all upgraded their price targets, with the highest being $29. Analysts cite lower supply driving price action, potential price uplift in petchems, and attractive valuation as key reasons for their optimism.

Wall Street analysts forecast CC stock price to fall
7 Analyst Rating
Wall Street analysts forecast CC stock price to fall
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 23.320
sliders
Low
13
Averages
16.14
High
19
Current: 23.320
sliders
Low
13
Averages
16.14
High
19
RBC Capital
Arun Viswanathan
Outperform
maintain
$21 -> $26
AI Analysis
2026-04-10
Reason
RBC Capital
Arun Viswanathan
Price Target
$21 -> $26
AI Analysis
2026-04-10
maintain
Outperform
Reason
RBC Capital analyst Arun Viswanathan raised the firm's price target on Chemours to $26 from $21 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results among Commodity Chemicals names. Recent conversations with investor relations teams have indicated that lower supply is driving price action across petchems, with the potential for significant price uplift in the first half of the year to drive stronger earnings than previously expected, the analyst tells investors in a research note.
UBS
Buy
maintain
$23 -> $29
2026-04-09
Reason
UBS
Price Target
$23 -> $29
2026-04-09
maintain
Buy
Reason
UBS raised the firm's price target on Chemours to $29 from $23 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CC
Unlock Now

People Also Watch